Sign In
Stocks
News
ETFs
Economy
Currencies
Press Releases
NASDAQ:TCBPW Warrant Quote
Last Price
0.0060
Change
+0.00 (0.00%)
TC BioPharm (Holdings) plc - Warrants is a warrant that trades on the Nasdaq Stock Exchange
Summary
News
Press Releases
Chart
Historical
TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
benzinga.com
TC Biopharm (
NASDAQ: TCBP
) (
NASDAQ: TCBPW
) recently announced the dosing of its first three patients within its Phase 2b clinical trial of OmnImmune®,
Via
Benzinga
· November 22, 2022